Epstein-Barr virus-associated acute disseminated encephalomyelitis successfully treated with rituximab: a case report
Seoyeon Kim, Seon-Jae Ahn, Kon Chu
encephalitis. 2021;1(3):85-88.   Published online 2021 Jun 7     DOI: https://doi.org/10.47936/encephalitis.2021.00066
Citations to this article as recorded by Crossref logo
Successful Treatment of Epstein-Barr Virus Reactivation-associated Transverse Myelitis Following Herpes Zoster with Intravenous Rituximab in a Cord Blood Transplant Recipient
Keijiro Sato, Rie Watanabe, Ichiro Ito, Ken-Ich Imadome, Masahiko Sumi, Hikaru Kobayashi
Internal Medicine.2024;[Epub]     CrossRef
Unpacking the CNS Manifestations of Epstein-Barr Virus: An Imaging Perspective
N. Soni, M. Ora, R. Singh, P. Mehta, A. Agarwal, G. Bathla
American Journal of Neuroradiology.2023; 44(9): 1002.     CrossRef
Successful treatment with rituximab for central nervous system vasculitis caused by Epstein-Barr virus-associated lymphoproliferative disorder with immunoglobulin M gammopathy
Juhee Lee, Han Sang Lee, Kon Chu
encephalitis.2022; 2(1): 14.     CrossRef
Epstein-Barr virus meningoencephalitis in a young immunocompetent child: A case report
Sipang Pangprasertkul, Chinnuwat Sanguansermsri, Tavitiya Sudjaritruk
Heliyon.2022; 8(10): e11150.     CrossRef